FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896090003> ?p ?o ?g. }

• W2896090003 endingPage "231" @default.
• W2896090003 startingPage "223" @default.
• W2896090003 abstract "Imiquimod (IMQ) is an immunostimulant drug topically used for the treatment of actinic keratosis and basal cell carcinoma. IMQ formulation and skin delivery is difficult because of its very low solubility in the most of pharmaceutical excipients and very poor skin penetration properties. The purpose of this study was to develop a microemulsion to optimize imiquimod skin delivery using d‑α‑tocopherol polyethylene glycol-1000 succinate (TPGS) as surfactant (so as to take advantage of its thickening properties) and isostearic acid as oil phase. This fatty acid was selected since it has demonstrated a good solubilizing power for imiquimod and it has also shown to contribute to its therapeutic activity. We have built pseudo-ternary diagrams using two different co-surfactants (Transcutol® and propylene glycol - PG) in a 1:1 ratio with TPGS and then selected microemulsions in the clear and viscous regions of the diagrams. The systems were characterized in terms of rheology and X-ray scattering; additionally, the capability to promote IMQ skin uptake was evaluated ex-vivo on a porcine skin model. All the formulations selected in the gel-microemulsion regions behaved as viscoelastic solids; X-rays scattering experiments revealed in all cases the presence of an ordered lamellar structure, but with differences in terms of interlamellar distance and flexibility between Transcutol® and PG–containing systems. A higher flexibility and a greater hydrophobic volume, possibly interconnected at some point, was associated to the use of Transcutol® and had an impact on the microemulsion capacity to solubilize IMQ as well as on the capability to enhance drug uptake into the skin. The best performing gel-like microemulsion was composed of ≈26% of water, ≈21% of isostearic acid, ≈26% of TPGS and ≈27% of Transcutol® and accumulated, after 6 h of contact, 3.0 ± 1.1 μg/cm2 of IMQ. This value is higher than the one reported in the literature for the commercial cream (1.9 ± 0.8 μg/cm2), despite the 4-times lower concentration of the vehicle (13 mg/g for the microemulsion vs 50 mg/g for the commercial cream)." @default.
• W2896090003 created "2018-10-26" @default.
• W2896090003 creator A5012650397 @default.
• W2896090003 creator A5016377364 @default.
• W2896090003 creator A5033794388 @default.
• W2896090003 creator A5054458617 @default.
• W2896090003 creator A5070016119 @default.
• W2896090003 creator A5076630196 @default.
• W2896090003 creator A5077920521 @default.
• W2896090003 creator A5078424915 @default.
• W2896090003 date "2018-12-01" @default.
• W2896090003 modified "2023-10-17" @default.
• W2896090003 title "Microemulsions based on TPGS and isostearic acid for imiquimod formulation and skin delivery" @default.
• W2896090003 cites W1515777772 @default.
• W2896090003 cites W1846953774 @default.
• W2896090003 cites W1977502763 @default.
• W2896090003 cites W1989120657 @default.
• W2896090003 cites W1995821683 @default.
• W2896090003 cites W2001020866 @default.
• W2896090003 cites W2007545931 @default.
• W2896090003 cites W2016220398 @default.
• W2896090003 cites W2020389958 @default.
• W2896090003 cites W2045128339 @default.
• W2896090003 cites W2060265857 @default.
• W2896090003 cites W2061215349 @default.
• W2896090003 cites W2075411238 @default.
• W2896090003 cites W2137007241 @default.
• W2896090003 cites W2271160382 @default.
• W2896090003 cites W2489429174 @default.
• W2896090003 cites W2517555830 @default.
• W2896090003 cites W2543145801 @default.
• W2896090003 cites W2571134977 @default.
• W2896090003 cites W2624871345 @default.
• W2896090003 cites W2748929058 @default.
• W2896090003 cites W2768413943 @default.
• W2896090003 cites W2782905057 @default.
• W2896090003 cites W2801167590 @default.
• W2896090003 cites W4249118394 @default.
• W2896090003 doi "https://doi.org/10.1016/j.ejps.2018.10.007" @default.
• W2896090003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30316975" @default.
• W2896090003 hasPublicationYear "2018" @default.
• W2896090003 type Work @default.
• W2896090003 sameAs 2896090003 @default.
• W2896090003 citedByCount "20" @default.
• W2896090003 countsByYear W28960900032019 @default.
• W2896090003 countsByYear W28960900032020 @default.
• W2896090003 countsByYear W28960900032021 @default.
• W2896090003 countsByYear W28960900032022 @default.
• W2896090003 countsByYear W28960900032023 @default.
• W2896090003 crossrefType "journal-article" @default.
• W2896090003 hasAuthorship W2896090003A5012650397 @default.
• W2896090003 hasAuthorship W2896090003A5016377364 @default.
• W2896090003 hasAuthorship W2896090003A5033794388 @default.
• W2896090003 hasAuthorship W2896090003A5054458617 @default.
• W2896090003 hasAuthorship W2896090003A5070016119 @default.
• W2896090003 hasAuthorship W2896090003A5076630196 @default.
• W2896090003 hasAuthorship W2896090003A5077920521 @default.
• W2896090003 hasAuthorship W2896090003A5078424915 @default.
• W2896090003 hasBestOaLocation W28960900032 @default.
• W2896090003 hasConcept C16005928 @default.
• W2896090003 hasConcept C178790620 @default.
• W2896090003 hasConcept C185592680 @default.
• W2896090003 hasConcept C190119865 @default.
• W2896090003 hasConcept C192562407 @default.
• W2896090003 hasConcept C2776964284 @default.
• W2896090003 hasConcept C2779112978 @default.
• W2896090003 hasConcept C2779717098 @default.
• W2896090003 hasConcept C2779783494 @default.
• W2896090003 hasConcept C33923547 @default.
• W2896090003 hasConcept C42475967 @default.
• W2896090003 hasConcept C43617362 @default.
• W2896090003 hasConcept C55493867 @default.
• W2896090003 hasConcept C58226133 @default.
• W2896090003 hasConcept C71924100 @default.
• W2896090003 hasConcept C80107235 @default.
• W2896090003 hasConceptScore W2896090003C16005928 @default.
• W2896090003 hasConceptScore W2896090003C178790620 @default.
• W2896090003 hasConceptScore W2896090003C185592680 @default.
• W2896090003 hasConceptScore W2896090003C190119865 @default.
• W2896090003 hasConceptScore W2896090003C192562407 @default.
• W2896090003 hasConceptScore W2896090003C2776964284 @default.
• W2896090003 hasConceptScore W2896090003C2779112978 @default.
• W2896090003 hasConceptScore W2896090003C2779717098 @default.
• W2896090003 hasConceptScore W2896090003C2779783494 @default.
• W2896090003 hasConceptScore W2896090003C33923547 @default.
• W2896090003 hasConceptScore W2896090003C42475967 @default.
• W2896090003 hasConceptScore W2896090003C43617362 @default.
• W2896090003 hasConceptScore W2896090003C55493867 @default.
• W2896090003 hasConceptScore W2896090003C58226133 @default.
• W2896090003 hasConceptScore W2896090003C71924100 @default.
• W2896090003 hasConceptScore W2896090003C80107235 @default.
• W2896090003 hasLocation W28960900031 @default.
• W2896090003 hasLocation W28960900032 @default.
• W2896090003 hasLocation W28960900033 @default.
• W2896090003 hasOpenAccess W2896090003 @default.
• W2896090003 hasPrimaryLocation W28960900031 @default.
• W2896090003 hasRelatedWork W2048819034 @default.
• W2896090003 hasRelatedWork W2085379202 @default.

• next